Caris Common Stock Shares Outstanding from 2010 to 2026

CAI Stock  USD 25.00  0.55  2.15%   
Caris Life's Common Stock Shares Outstanding is increasing with slightly volatile movements from year to year. Common Stock Shares Outstanding is estimated to finish at about 307.5 M this year. Common Stock Shares Outstanding is the total number of shares of a company's common stock that are currently owned by all its shareholders. View All Fundamentals
 
Common Stock Shares Outstanding  
First Reported
2006-03-31
Previous Quarter
276 M
Current Value
297.2 M
Quarterly Volatility
65.4 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Caris Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Caris Life's main balance sheet or income statement drivers, such as Depreciation And Amortization of 61.8 M, Interest Expense of 33.1 M or Total Revenue of 497.8 M, as well as many indicators such as Price To Sales Ratio of 16.34, Dividend Yield of 0.0333 or Days Sales Outstanding of 175. Caris financial statements analysis is a perfect complement when working with Caris Life Valuation or Volatility modules.
  
Build AI portfolio with Caris Stock
Check out the analysis of Caris Life Correlation against competitors.

Latest Caris Life's Common Stock Shares Outstanding Growth Pattern

Below is the plot of the Common Stock Shares Outstanding of Caris Life Sciences over the last few years. It is the total number of shares of a company's common stock that are currently owned by all its shareholders. Caris Life's Common Stock Shares Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Caris Life's overall financial position and show how it may be relating to other accounts over time.
Common Stock Shares Outstanding10 Years Trend
Slightly volatile
   Common Stock Shares Outstanding   
       Timeline  

Caris Common Stock Shares Outstanding Regression Statistics

Arithmetic Mean108,215,843
Geometric Mean50,038,690
Coefficient Of Variation114.40
Mean Deviation114,114,738
Median21,155,000
Standard Deviation123,799,924
Sample Variance15326.4T
Range289.6M
R-Value0.84
Mean Square Error4811.6T
R-Squared0.71
Significance0.000024
Slope20,594,594
Total Sum of Squares245222.7T

Caris Common Stock Shares Outstanding History

2026307.5 M
2025292.9 M
2023254.7 M
2021254.8 M
202017.9 M
201918 M
201819.8 M

About Caris Life Financial Statements

Investors use fundamental indicators, such as Caris Life's Common Stock Shares Outstanding, to determine how well the company is positioned to perform in the future. Although Caris Life's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Common Stock Shares Outstanding292.9 M307.5 M

Currently Active Assets on Macroaxis

When determining whether Caris Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Caris Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Caris Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Caris Life Sciences Stock:
Check out the analysis of Caris Life Correlation against competitors.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Trading Companies & Distributors space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Caris Life. If investors know Caris will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Caris Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.25)
Revenue Per Share
3.18
Quarterly Revenue Growth
0.499
The market value of Caris Life Sciences is measured differently than its book value, which is the value of Caris that is recorded on the company's balance sheet. Investors also form their own opinion of Caris Life's value that differs from its market value or its book value, called intrinsic value, which is Caris Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Caris Life's market value can be influenced by many factors that don't directly affect Caris Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Caris Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Caris Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Caris Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.